NAV
₹10.0300
as on 20 Aug 2019 09:25 PM
₹-0.0100(0.10%)
Last Change
Schemes Managed By
Investment Performance
would have given a returns of
₹100,291
₹100,562
₹99,701
₹99,900
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹100
Profit (absolute return)
0.10%
in the last
1m
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
NA
In the last 6 months
NA
In the last 1 year
NA
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Dividend
as of 20 Aug 2019 09:25 PM
₹150.86 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.5% if redeemed within 90 days.
NA
Expense Ratio
Plan
Dividend
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 0.5% if redeemed within 90 days.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Jul 2019
Healthcare
79.16%
₹119.42 Cr
Chemicals
3.67%
₹5.53 Cr
FMCG
3.25%
₹4.91 Cr
Cash Holding
-0.30%
₹-45.75 Lakh
Companies Holding in this Mutual Fund
as on 31 Jul 2019
Others
13.92%
₹21.00 Cr
Sun Pharmaceutical Inds. Ltd.
10.24%
₹15.45 Cr
Lupin Ltd.
9.19%
₹13.86 Cr
Divi's Laboratories Ltd.
7.86%
₹11.86 Cr
Cipla Ltd.
5.18%
₹7.81 Cr
Torrent Pharmaceuticals Ltd.
4.98%
₹7.51 Cr
Apollo Hospitals Enterprise Ltd.
4.93%
₹7.44 Cr
Dr. Reddy's Laboratories Ltd.
4.73%
₹7.14 Cr
Sanofi India Ltd.
4.02%
₹6.06 Cr
Alkem Laboratories Ltd.
3.86%
₹5.82 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Jul 2019
Others
13.92%
₹21.00 Cr
Sun Pharmaceutical Inds. Ltd.
10.24%
₹15.45 Cr
Lupin Ltd.
9.19%
₹13.86 Cr
Divi's Laboratories Ltd.
7.86%
₹11.86 Cr
Cipla Ltd.
5.18%
₹7.81 Cr
Torrent Pharmaceuticals Ltd.
4.98%
₹7.51 Cr
Apollo Hospitals Enterprise Ltd.
4.93%
₹7.44 Cr
Dr. Reddy's Laboratories Ltd.
4.73%
₹7.14 Cr
Sanofi India Ltd.
4.02%
₹6.06 Cr
Alkem Laboratories Ltd.
3.86%
₹5.82 Cr
View All
View All
This fund's returns:
0.10%Return Duration
1 Month
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
-1.35%
0.44%
1M Returns
0.44
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹1000
Category Returns
-1.35%
0.44%
1M Returns
0.13
IDBI Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
-1.35%
0.44%
1M Returns
0.00
Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
-1.35%
0.44%
1M Returns
-0.10
Tata India Pharma & HealthCare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
-1.35%
0.44%
1M Returns
-0.38
About Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Dividend
Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Dividend is a Equity mutual fund scheme from Aditya Birla Sun Life Mutual Fund. This scheme was launched on 10 Jul 2019 and is currently managed by its fund manager Dhaval Shah. It has an AUM of ₹150.86 Crores and the latest NAV decalared is ₹10.030 as on 20 Aug 2019 at 9:25 pm.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Dividend scheme return performance is -0.20% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Objective
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Scheme Details
| AUM: | ₹150.86 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 10 Jul 2019 |
| Fund Type: | Open-End |
AMC Information
Aditya Birla Sun Life Mutual Fund
View AMC Details
₹254,111.13 Cr
AUM
118
Schemes
Address
One India Bulls Center - Tower 1,17th Floor - Jupiter Mills Compound,841 Senapati Bhawan, Elphinstone Road,400013
Phone Number
Phone : 022-43568000/ 1800-270-7000/ 1800-22-7000
Fax : 022- 43568110
Email / Website